USA – COVID-19 guidelines updated to include steroids

The Infectious Diseases Society of America (IDSA) has updated its treatment guidelines to include generic steroid pills for patients hospitalized with severe COVID-19, the disease caused by the new coronavirus.

The only other drug the medical group recommends for COVID-19 patients outside of a clinical trial is remdesivir, the intravenous antiviral medication made by Gilead Sciences Inc (GILD.O).

The IDSA late on Thursday said its change was based on recent data from a United Kingdom study showing that a low-cost and widely used steroid called dexamethasone reduced death rates by around a third among the most severely ill hospitalized COVID-19 patients…